Airfinity’s next industry roundtable will see experts across respiratory diseases and pandemic preparedness come together to discuss Airfinity’s ‘tripledemic’ forecasts, vaccine and treatment demand, and the impact of new medical countermeasures on disease outcomes.
We’re also pleased to announce our first panellist as Anant Shah, Commercial New Products Lead, COVID and Respiratory Combo Vaccines at Moderna. Anant has over 20 years of experience in public health, infectious diseases, and vaccine development.
Join us online on Wednesday 6th September at 11am ET/4pm BST to learn more about the ongoing seasonal burden of influenza, RSV, and COVID19.